Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$1.16 - $2.74 $8,352 - $19,728
-7,200 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$2.62 - $5.43 $76,242 - $158,013
-29,100 Reduced 80.17%
7,200 $19,000
Q2 2021

Aug 16, 2021

BUY
$5.06 - $8.15 $80,960 - $130,400
16,000 Added 78.82%
36,300 $192,000
Q1 2021

May 17, 2021

BUY
$6.24 - $9.58 $124,800 - $191,600
20,000 Added 6666.67%
20,300 $137,000
Q4 2020

Feb 16, 2021

BUY
$6.28 - $8.79 $1,884 - $2,636
300 New
300 $2,000
Q3 2020

Nov 16, 2020

SELL
$7.5 - $11.11 $286,500 - $424,402
-38,200 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$8.33 - $13.79 $318,206 - $526,778
38,200 New
38,200 $401,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $9.08M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.